Very early researchUnknownNCT05528354
What this trial is testing
Venetoclax and Decitabin Based Conditioning Regimen Followed With Post-HSCT Decitabin Maintenance Therapy in TP53 Mutant AML/MDS Patients
Who this might be right for
Hematopoietic Stem Cell TransplantationTP53
Zhejiang University 58